Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Combining PRP and minoxidil is more effective for hair loss than using either alone.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Combining platelet-rich products, biomaterials, and bioactive substances may improve skin treatment, but more research is needed.

New treatments improved blood pressure control in patients with resistant hypertension.

Thallium is highly toxic, causing severe health issues, and Prussian blue is the best antidote.

Oral testosterone therapy raises heart risk more than other methods.

Platelet-rich plasma may help heal injuries.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.